1.82
Precedente Chiudi:
$1.80
Aprire:
$1.8
Volume 24 ore:
49,584
Relative Volume:
1.06
Capitalizzazione di mercato:
$41.26M
Reddito:
$35.16M
Utile/perdita netta:
$-11.44M
Rapporto P/E:
-3.0532
EPS:
-0.5961
Flusso di cassa netto:
$-15.44M
1 W Prestazione:
-1.09%
1M Prestazione:
-19.47%
6M Prestazione:
-57.77%
1 anno Prestazione:
-76.08%
Bioharvest Sciences Inc Stock (BHST) Company Profile
Nome
Bioharvest Sciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare BHST vs JBS, KHC, GIS, MKC, SJM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BHST
Bioharvest Sciences Inc
|
1.82 | 46.24M | 35.16M | -11.44M | -15.44M | -0.5961 |
|
JBS
Jbs Nv
|
13.03 | 44.57B | 88.25B | 1.91B | -681.64M | 1.6761 |
|
KHC
Kraft Heinz Co
|
24.85 | 30.32B | 24.99B | -5.76B | 3.95B | -4.863 |
|
GIS
General Mills Inc
|
38.29 | 21.18B | 18.42B | -85.30M | 1.63B | -0.1894 |
|
MKC
Mccormick Co Inc
|
52.08 | 14.85B | 7.39B | 1.63B | 1.02B | 6.0085 |
|
SJM
J M Smucker Co
|
126.08 | 13.15B | 9.05B | -138.70M | 1.16B | -1.307 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Roth Capital | Buy |
| 2025-05-05 | Iniziato | Craig Hallum | Buy |
| 2024-12-18 | Iniziato | Maxim Group | Buy |
Bioharvest Sciences Inc Borsa (BHST) Ultime notizie
BioHarvest (BHST) Daily Price Brief: Finishes 2.76% Down at $2.11 at the Close; Session Range View: Price Remains Between $2.00 Support and $2.22 Resistance in Latest TradingLow Volatility Picks - vinanet.vn
BioHarvest (BHST) Earnings Recap: The Available Earnings Metric Delivers a Miss in the Reported Period; The Stock Loses 1.15% in the Available RecordEarnings Manipulation Risk - Vinanet
symbol__ Stock Quote Price and Forecast - CNN
BHST Looks 70.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BHST Q1 2025 Earnings: Wider-Than-Expected Loss Sends Shares DownEarnings Trend Analysis - vinanet.vn
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BioHarvest Sciences Inc. (BHST) Jumps 6%: Breaking Toward Resistance at $2.31Gap Down Bounce Plays - Vinanet
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Maxim Group Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $5 - Moomoo
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
What Will BioHarvest Sciences (NASDAQ:BHST) Add to Nasdaq Focus? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
What Is BioHarvest Sciences (NASDAQ:BHST) Nasdaq Composite Focus? - kalkinemedia.com
BioHarvest Sciences cuts FY26 sales guidance to $37-40 million - scanx.trade
Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
BioHarvest Sciences Q2 Earnings Call Highlights - marketbeat.com
BioHarvest Sciences: Secured first major CDMO contract and reaffirmed 2027 EBITDA breakeven despite revised 2026 guidance - TradingView
BioHarvest Sciences: Secured a transformative fragrance CDMO contract, driving revenue growth and 2027 EBITDA breakeven - TradingView
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss - Investing.com
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound - finance.yahoo.com
BioHarvest Sciences shares surge 11% after major fragrance manufacturing deal - Yahoo Finance
BioHarvest Sciences shares surge 11% on major fragrance deal By Investing.com - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioHarvest secures fragrance manufacturing deal worth $20-30M By Investing.com - Investing.com Australia
BioHarvest secures first CDMO manufacturing dea... - pluang.com
BioHarvest Sciences shares surge 11% on major fragrance deal - Investing.com
BioHarvest Sciences: Q2 revenue up 3.8% to $8.8M; first CDMO deal signed; full-year guidance revised downward - TradingView
BioHarvest secures fragrance manufacturing deal worth $20-30M - Investing.com
BioHarvest Sciences Reports Q2 2026 Results, Secures First CDMO Fragrance Manufacturing Agreement for 20-Ton Production Program - kalkine.ca
BioHarvest inks exclusive deal to produce rare luxury fragrance, targeting $20-$30M revenue by 2027. - Pluang
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance - TMX Newsfile
BioHarvest Sciences Secures 20-Tonne Rare Fragrance Manufacturing Deal Estimated at $20–$30 Million in Revenue - kalkine.ca
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Gardner leaders tour Biosynth to boost local economy - AOL.com
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - 富途牛牛
BioHarvest Sciences (BHST) Holds Steady at $2.26, Trapped Between $2.15 Support and $2.37 ResistanceRetail Volume - dars.gov.et
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – FWB:8MV0 - TradingView
Pivot Bio to Honor 15 Under 20 Global Fields of Promise Fellows - AOL.com
BioHarvest Sciences (BHST) Posts Modest Gain, Holds Between Key Support and ResistanceHigh Conviction Picks - vinanet.vn
Bioharvest Sciences Inc Azioni (BHST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):